MSM does its best to slant almost every news story in favor of embryonic stem cell research, or at least not against it. But in the interest of “fairness,” it is forced to quickly type – in teeny-tiny font size – little truths in the midst of its spin, expecting people not to notice. Most don’t. But these embryonic truths are indeed buried in most stem cell stories, for the discerning eye to spot.
Such as today….
“Using stem cells derived from the patient’s own spinal cord, a team of Korean scientists have revived the damaged part of his brain,” reported Seoul, South Korea’s Chosun.com today. The article added that 64 of 74 patients treated for various arterial and bone disorders with their own spinal cord cells showed “significant improvement without any signs of side effects” (emphases mine).
That’s a great story (no one will hear about), but stop. What are the side effects? ABCNews.com added that researchers reported “no side effects such as immunity rejection during the therapy” (emphasis mine).
The best kept secret of ESCR is that it will fail without human cloning. It’s all about the match. We’re all familiar with this concept due to the decades-old bone marrow (one type of adult stem cell) transplant program. A key to treatment is finding an exact match between donor and recipient.
All these embryonic stem cell experiments that researchers are trying to get taxpayers to fund on the premise of treating just about every disease known to humankind will rarely if ever match recipients, because embryos are unique humans who grow their own unique cells.
This is why human cloning is so closely tied to ESCR. Only cloning will result in guaranteed exact matches. Just try to get rid of cloning – excuse me, somatic cell nuclear transfer – verbiage in legislation. Go ahead, try. They’ll bite your head off (and probably steal your stem cells).
This is why we’re having so much trouble passing anti-cloning legislation federally and in various states. To do so would cause ESCR to die in the petri dish.